UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 252

Sortiert nach

Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes

Liver international, 2018-11, Vol.38 (11), p.2018-2027

Tseng, Chin‐Hsiao

2018

Link zum Volltext

Verfügbarkeit prüfen

Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study

Otolaryngology-head and neck surgery, 2023-06, Vol.168 (6), p.1389-1400

Tseng, Chin‐Hsiao

2023

Link zum Volltext

Verfügbarkeit prüfen

Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes

PloS one, 2014-10, Vol.9 (10), p.e109852

2014

Link zum Volltext

Verfügbarkeit prüfen

Metformin and the Risk of Dementia in Type 2 Diabetes Patients

Aging and disease, 2019-02, Vol.10 (1), p.37-48

Tseng, Chin-Hsiao

2019

Link zum Volltext

Verfügbarkeit prüfen

Thyroid cancer risk is not increased in diabetic patients

PloS one, 2012-12, Vol.7 (12), p.e53096

2012

Link zum Volltext

Verfügbarkeit prüfen

Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis

Journal of the American Heart Association, 2019-11, Vol.8 (21), p.e011640

Tseng, Chin-Hsiao

2019

Link zum Volltext

Verfügbarkeit prüfen

Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus

Scientific reports, 2021-06, Vol.11 (1), p.1-11, Article 12400

Tseng, Chin-Hsiao

2021

Link zum Volltext

Verfügbarkeit prüfen

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus

Diabetes/metabolism research and reviews, 2015-09, Vol.31 (6), p.619-626

Tseng, Chin-Hsiao

2015

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature

Biomolecules (Basel, Switzerland), 2021-07, Vol.11 (7), p.1022

Tseng, Chin-Hsiao

2021

Link zum Volltext

Verfügbarkeit prüfen

Metformin reduces risk of varicose veins in patients with type 2 diabetes

Diabetes/metabolism research and reviews, 2020-02, Vol.36 (2), p.e3206-n/a

Tseng, Chin‐Hsiao

2020

Link zum Volltext

Verfügbarkeit prüfen

Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus

Pharmaceuticals (Basel, Switzerland), 2022-12, Vol.15 (12), p.1538

Tseng, Chin-Hsiao

2022

Link zum Volltext

Verfügbarkeit prüfen

Metformin’s effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study

Frontiers in pharmacology, 2022-07, Vol.13, p.799290-799290

Tseng, Chin-Hsiao

2022

Link zum Volltext

Verfügbarkeit prüfen

Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients

Frontiers in endocrinology (Lausanne), 2023-07, Vol.14, p.1185053-1185053

Tseng, Chin-Hsiao

2023

Link zum Volltext

Verfügbarkeit prüfen

Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan

Cancers, 2023-08, Vol.15 (17), p.4276

Tseng, Chin-Hsiao

2023

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus

Cancers, 2022-11, Vol.14 (22), p.5637

Tseng, Chin-Hsiao

2022

Link zum Volltext

Verfügbarkeit prüfen

Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients

Pharmaceuticals (Basel, Switzerland), 2023-05, Vol.16 (5), p.679

Tseng, Chin-Hsiao

2023

Link zum Volltext

Verfügbarkeit prüfen

Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance

PloS one, 2015-11, Vol.10 (11), p.e0142480-e0142480

2015

Link zum Volltext

Verfügbarkeit prüfen

Metformin Reduces the Risk of Diverticula of Intestine in Taiwanese Patients with Type 2 Diabetes Mellitus

Frontiers in pharmacology, 2021-09, Vol.12, p.739141-739141

Tseng, Chin-Hsiao

2021

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin

Pharmaceuticals (Basel, Switzerland), 2023-02, Vol.16 (2), p.224

Tseng, Chin-Hsiao

2023

Link zum Volltext

Verfügbarkeit prüfen

Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus

Frontiers in pharmacology, 2021-02, Vol.11, p.578831

Tseng, Chin-Hsiao

2021

Link zum Volltext

Verfügbarkeit prüfen

Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes

European journal of clinical investigation, 2016-01, Vol.46 (1), p.70-79

Tseng, Chin-Hsiao

2016

Link zum Volltext

Verfügbarkeit prüfen

Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes

Frontiers in oncology, 2020-10, Vol.10, p.587666

Tseng, Chin-Hsiao

2020

Link zum Volltext

Verfügbarkeit prüfen

Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study

PloS one, 2014-07, Vol.9 (7), p.e101553

2014

Link zum Volltext

Verfügbarkeit prüfen

Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients

Frontiers in endocrinology (Lausanne), 2021-04, Vol.12, p.637392-637392

Tseng, Chin-Hsiao

2021

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and gastric cancer: The potential links

World journal of gastroenterology : WJG, 2014-02, Vol.20 (7), p.1701-1711

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(208)
Life Sciences & Biomedicine
(191)
Humans
(167)
Female
(123)
Male
(120)
Middle Aged
(115)
Taiwan
(108)
Risk Factors
(100)
Aged
(97)
Taiwan - Epidemiology
(84)
Adult
(77)
Diabetes
(71)
Diabetes Mellitus
(67)
Diabetes Mellitus, Type 2 - Drug Therapy
(58)
Biological And Medical Sciences
(53)
Medical Sciences
(53)
Diabetes Mellitus, Type 2 - Complications
(52)
Incidence
(50)
Endocrinology & Metabolism
(48)
Metformin
(45)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes

Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study

Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes

Metformin and the Risk of Dementia in Type 2 Diabetes Patients

Thyroid cancer risk is not increased in diabetic patients

Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis

Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus

The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature

Metformin reduces risk of varicose veins in patients with type 2 diabetes

Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus

Metformin’s effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study

Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients

Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan

The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus

Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients

Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance

Metformin Reduces the Risk of Diverticula of Intestine in Taiwanese Patients with Type 2 Diabetes Mellitus

The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin

Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus

Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes

Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes

Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study

Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients

Diabetes and gastric cancer: The potential links

Suchergebnisse filtern